BIG PHARMA WATCH: MERCK TAKES ANOTHER STEP TOWARD FURTHER EXTENDING PATENT EXCLUSIVITY ON BLOCKBUSTER CANCER DRUG KEYTRUDA
Big Pharma Giant Proceeds With Strategy to Block Competition, Add More Patents… Read More
Big Pharma Giant Proceeds With Strategy to Block Competition, Add More Patents… Read More
Congress Should Not Further Consider Misguided Proposal That Would Enable More… Read More
Study Finds Big Pharma’s Price-Gouging and Patent Abuse Playbook Fuels… Read More
Brand Name Manufacturers Continue to Charge U.S. Patients Highest Prices in… Read More
Gilead CEO Touts Success of Company’s Patent Playbook on HIV Portfolio That… Read More
Lawmakers Should Remain Focused on Holding Big Pharma Accountable for… Read More
Big Pharma Giants Conclude Latest Round of Earnings Reports Fueled by… Read More
Big Pharma Giants Keep Beating Wall Street Expectations While Continuing to… Read More
Big Pharma Giants Rolling in Strong Earnings While Continuing to Hike Drug… Read More
Big Pharma Giants Continue Reporting Expectation-Beating Q3 Earnings After… Read More
Eli Lilly Opinion Column Reiterates Debunked Arguments on Innovation as Brand… Read More
Johnson & Johnson Reports Higher-Than-Expected Earnings Fueled by Price… Read More